Comparative Study of Usefulness of TAZ/PIPC and MEPM in Healthcare Associated Pneumonia (HCAP): Survey on the Actual Condition of Healthcare Associated Pneumonia (HCAP) in Japan - Comparative Study of Usefulness of TAZ/PIPC and MEPM in HCAP

agasaki evaluation organization for clinical interventions0 个研究点目标入组 100 人开始时间: 2009年8月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•*Patients with bronchial obstruction or the history of obstructive pneumonia. The patients with COPD, however, are not excluded. *Patients who can not tolerate the administration of selected drug three times a day. *Patients placed on chronic maintenance dialysis *Patients with serious hepatic dysfunction and renal dysfunction(CCr 30 ml/min or under ; -See the separate list of Scr.) *Patients who have difficulty in judgment of the efficacy of selected drug (including patients suffering from cancer or other underlying diseases which prevent the evaluation). *Patients infected probably with MRSA *Patients who are given corticosteroid (prednisolone more than 10 mg/day) *Patients with the history of hypersensitivity to the ingredients of selected drug, penicillin antimicrobials or carbapenem antimicrobials *Pregnant or breastfeeding patients, or patients who have the possibility of being pregnant *Patients with infectious mononucleosis *Patients who were judged as ineligible by their treating physicians

发起方

agasaki evaluation organization for clinical interventions